NCT02724683

Brief Summary

The purpose of this study is to determine whether drainage with the usage of a fine, patient-controlled vascular catheter inserted into abdominal cavity is a feasible, safe and effective method in the management of symptomatic malignant ascites. Complications' rate of the procedure and patients' quality of life, nutritional status and experience on the treatment are main endpoints.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 31, 2016

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

February 23, 2023

Status Verified

February 1, 2023

Enrollment Period

7.6 years

First QC Date

March 20, 2016

Last Update Submit

February 22, 2023

Conditions

Keywords

ascitesdrainagecathetersymptomsmanagementquality of lifemalignantcancer

Outcome Measures

Primary Outcomes (2)

  • Number of participants with adverse events.

    Early and late adverse events of the catheter placement and later drainage to be recorded.

    2 weeks

  • Change in quality of life.

    Change in quality of life measured with standard questionnaire EORTC-C15-PAL before the procedure and 1-2 weeks later.

    2 weeks

Secondary Outcomes (4)

  • Number of participants with drainage complication during cancer treatment vs observation.

    1 month

  • Number of participants with successful catheter placement.

    2 weeks

  • Patient's experience on the treatment.

    2 weeks

  • Change in nutrition habits.

    2 weeks

Other Outcomes (2)

  • Change in nutrition status among participants with prolonged ascites drainage.

    1 month

  • Number of ambulatory visits or hospital admissions.

    1 month

Study Arms (1)

Symptomatic ascites drainage with CVC.

Patients with malignant, symptomatic, refractory ascites. Ascites drainage with vascular catheter (CVC) inserted into abdominal cavity will be performed. Patients will be asked to complete interview, quality of life questionnaire, nutritional status assessment and quality of procedure survey.

Device: Ascites drainage with vascular catheter.Behavioral: Interview.Behavioral: Quality of life.Device: Quality of procedure.Other: Nutritional status

Interventions

In case of symptomatic malignant ascites, the procedure of vascular catheter insertion into abdominal cavity will be performed, followed by slow, systematic drainage, on patient's demand.

Symptomatic ascites drainage with CVC.
Interview.BEHAVIORAL

Interview with patients will be performed according to attached chart. The aim is to collect data concerning patient's symptoms, co-morbidity, and basic clinical data about the primary malignancy and treatment status.

Symptomatic ascites drainage with CVC.

Quality of life questionnaire (QLQ). Patients will be asked to complete QLQ at two time points: 1. immediately before the procedure, 2. one or two weeks after the procedure.

Symptomatic ascites drainage with CVC.

Patients will be asked to complete quality of procedure questionnaire at one time point: one or two weeks after the procedure.

Symptomatic ascites drainage with CVC.

Risk of malnutrition and ability to feed normally will be assessed with specific questionnaire at two time points: 1. immediately before the procedure, 2. one or two weeks after the procedure.

Symptomatic ascites drainage with CVC.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients considered eligible are those with malignant disease of any origin and coexisting symptomatic ascites who require a management anyway.

You may qualify if:

  • patients with symptomatic, refractory malignant ascites,
  • supportive care (professional or family members) available at patients' home,
  • informed signed consent of the patient.

You may not qualify if:

  • ascites not of malignant origin,
  • asymptomatic ascites,
  • suspected or clinically apparent infection especially at the site of planned drainage placement,
  • significant coagulopathy,
  • very poor performance status (PS4),
  • patient not able to read and sign informed consent,
  • mucinous ascites.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Central and Eastern European Gynecologic Oncology Group (CEEGOG)

Prague, Czechia

RECRUITING

Gdynia Oncology Center

Gdynia, 81-519, Poland

RECRUITING

Related Publications (6)

  • Hui D, Bruera E. Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol. 2016 Mar;13(3):159-71. doi: 10.1038/nrclinonc.2015.201. Epub 2015 Nov 24.

    PMID: 26598947BACKGROUND
  • Stephenson J, Gilbert J. The development of clinical guidelines on paracentesis for ascites related to malignancy. Palliat Med. 2002 May;16(3):213-8. doi: 10.1191/0269216302pm509oa.

  • Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer. 2006 Mar;42(5):589-97. doi: 10.1016/j.ejca.2005.11.018. Epub 2006 Jan 24.

  • Stukan M, Lesniewski-Kmak K, Wroblewska M, Dudziak M. Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter. Gynecol Oncol. 2015 Mar;136(3):466-71. doi: 10.1016/j.ygyno.2014.11.073. Epub 2014 Nov 28.

  • da Silva Fink J, Daniel de Mello P, Daniel de Mello E. Subjective global assessment of nutritional status - A systematic review of the literature. Clin Nutr. 2015 Oct;34(5):785-92. doi: 10.1016/j.clnu.2014.12.014. Epub 2014 Dec 26.

  • Stukan M. Drainage of malignant ascites: patient selection and perspectives. Cancer Manag Res. 2017 Apr 12;9:115-130. doi: 10.2147/CMAR.S100210. eCollection 2017.

MeSH Terms

Conditions

AscitesNeoplasms

Interventions

Vascular Access DevicesInterviews as TopicQuality of LifeNutritional Status

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CathetersEquipment and SuppliesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthHealth StatusDemographyEpidemiologic MeasurementsNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaPopulation Characteristics

Study Officials

  • Maciej Stukan, MD

    Gdynia Oncology Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Weeks
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 20, 2016

First Posted

March 31, 2016

Study Start

January 1, 2016

Primary Completion

August 1, 2023

Study Completion

December 1, 2023

Last Updated

February 23, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations